What do systematic reviews say?

135 mg/m2 paclitaxel vs 175 mg/m2 paclitaxel

The review found no eligible studies for this question.

• Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Weekly paclitaxel vs three‐weekly paclitaxel

The review found no eligible studies for this question.

• Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Continuous positive airway pressure (CPAP) vs sham CPAP

• Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  GRADE not reported

Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors

The review found no eligible studies for this question.

• Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Continuous positive airway pressure (CPAP) vs no CPAP

The review found no eligible studies for this question.

• Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

NB‐UVB vs UVA1

• Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 46 participants
  Very low

Botulinum toxin type A vs placebo

• Botulinum toxin type A therapy for cervical dystonia 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate

Botulinum toxin type A vs placebo

The review found no eligible studies for this question.

• Botulinum toxin type A therapy for blepharospasm 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Simulated presence therapy for dementia 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

CBT vs audiological care (tinnitus education and rehabilitation

• Cognitive behavioural therapy for tinnitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 410 participants
  Low

CBT vs TRT (directive counselling and bilateral masking)

• Cognitive behavioural therapy for tinnitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 42 participants
  Low

CBT vs no treatment or waiting list

• Cognitive behavioural therapy for tinnitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 179 participants
  Very low

Tivozanib vs sorafenib (targeted agent versus targeted agent)

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 506 participants
  Low

Sunitinib vs everolimus (targeted agent versus targeted agent)

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 288 participants
  Low

Pazopanib vs placebo (targeted agent versus placebo)

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 300 participants
  High

Intervention not reported

The review found no eligible studies for this question.

• Cryotherapy for liver metastases 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

TACE followed by 3‐DCRT vs chemoembolisation

• Transcatheter arterial chemoembolisation followed by three‐dimensional conformal radiotherapy versus transcatheter… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 66 participants
  Very low

Hyperbaric oxygen vs air breathing

The review found no eligible studies for this question.

• Hyperbaric oxygenation for tumour sensitisation to radiotherapy 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Gemcitabine plus cisplatin vs S‐1 plus cisplatin

The review found no eligible studies for this question.

• Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Gemcitabine plus S‐1 vs S‐1

The review found no eligible studies for this question.

• Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found